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Porcine circovirus type 2 (PCV2) is the essential etiological infectious agent of PCV2-systemic disease and has been
associated with other swine diseases, all of them collectively known as porcine circovirus diseases. MicroRNAs
(miRNAs) are a new class of small non-coding RNAs that regulate gene expression post-transcriptionally. miRNAs
play an increasing role in many biological processes. The study of miRNA-mediated host-pathogen interactions has
emerged in the last decade due to the important role that miRNAs play in antiviral defense. The objective of this
study was to identify the miRNA expression pattern in PCV2 subclinically infected and non-infected pigs. For this
purpose an experimental PCV2 infection was carried out and small-RNA libraries were constructed from tonsil
and mediastinal lymph node (MLN) of infected and non-infected pigs. High throughput sequencing determined
differences in miRNA expression in MLN between infected and non-infected while, in tonsil, a very conserved pattern
was observed. In MLN, miRNA 126-3p, miRNA 126-5p, let-7d-3p, mir-129a and mir-let-7b-3p were up-regulated whereas
mir-193a-5p, mir-574-5p and mir-34a down-regulated. Prediction of functional analysis showed that these miRNAs can
be involved in pathways related to immune system and in processes related to the pathogenesis of PCV2, although
functional assays are needed to support these predictions. This is the first study on miRNA gene expression in pigs
infected with PCV2 using a high throughput sequencing approach in which several host miRNAs were differentially
expressed in response to PCV2 infection.Introduction
Porcine circovirus type 2 (PCV2) belongs to the Circoviridae
family. The viral particle contains a single-strand circular
DNA genome of 1768-9 nucleotides (nt), enclosed within
a non-enveloped protein capsid with a diameter of 16- 18
nm. PCV2 is one of the smallest mammalian viruses en-
coding 11 potential reading frames, although expression
has only been determined from 3 of them. ORF1 encodes
the non-structural replication-associated protein Rep and
its truncated variant Rep’ [1], ORF2 encodes the structural
capsid protein Cap [2] and a non-structural protein with
an uncertain function is encoded by ORF3 [3]. Cap and
Rep/Rep’ carry out the two most elementary functions of a
virus, copying and the successive packaging of the viral
genome [4].
PCV2 is the etiological agent of PCV2-systemic disease
(PCV2-SD), formerly known as postweaning multisystemic* Correspondence: ignacio.nunez@cresa.uab.cat
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article, unless otherwise stated.wasting syndrome, (PMWS) [5], an emerging disease in
swine first described in 1991 [6]. PCV2 infection is wide-
spread and its most frequent manifestation is by means of a
subclinical infection. PCV2 is ubiquitous in swine livestock
worldwide, but it has been demonstrated that PCV2 DNA
load in serum is significantly higher in PCV2-SD affected
pigs than in healthy pigs, which is considered an indicator
of the disease [7]. PCV2-SD has a relatively high fatality rate
among 5 to 12-week-old pigs. The disease from a clinical
point of view causes dyspnea, a progressive loss of weight,
anemia, tachypnea, diarrhea and jaundice. Microscopic
lesions include lymphadenopathy, nephritis, pancreatitis,
hepatitis and granulomatous interstitial pneumonia [6].
PCV2 is thought to be involved in the pathogenesis of por-
cine dermatitis and nephropathy syndrome (PDNS), and is
linked with the occurrence of reproductive disease [5].
It has been suggested that PCV2 replicates firstly in the
tonsil and in the regional lymph nodes [6]. PCV2 patho-
genesis is related to the immunosuppression caused by the
virus in pigs [8] and changes in cytokine production caned Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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acquired PCV2-SD had an altered cytokine mRNA expres-
sion pattern with overexpression of IL-10 mRNA in thy-
mus and IFN-γ mRNA in tonsil, whereas a reduction in
the expression of IFN-γ, IL-10, IL-12p40, IL-4 and IL-2
mRNA was observed in other lymphoid tissues [9].
Nevertheless, the mechanisms involved in these processes
are poorly understood. This complexity is reflected, for ex-
ample, in IL-10 expression where a feedback regulation
between IL-10 and several microRNAs (miRNAs) has
been described [10].
miRNAs are 19-24 nt long non-coding ssRNAs that
regulate gene expression post-transcriptionally. De-
rived from hairpin precursors, they mediate the post-
transcriptional silencing of an estimated 30% of protein
coding genes in mammals by binding to complementary
sites typically located in the 3′ untranslated regions
(UTRs) of their target mRNAs [11,12]. This regulation of
gene expression via microRNA-mediated RNA interfer-
ence (RNAi) was first identified in Caenorhabditis elegans
in 1998. Since this time, more than 21 000 miRNAs have
been identified in all kind of species (miRNA registry at
miRBase [13]) from mammals, to plants [14], and more
recently in several viruses [15,16]. miRNAs have been
shown to be implicated in several biological processes
such as development, differentiation, homeostasis, car-
cinogenesis and a wide variety of diseases [17].
The biogenesis of miRNAs has been extensively de-
scribed in the literature [12,18], but it is considered that
there is a canonical pathway by which miRNAs are gen-
erated through consecutive cleavages of hairpin precur-
sors by two RNase III enzymes, Drosha and Dicer. In
the cell nucleus, the single strand-double strand junction
of the pri-miRNA hairpin is recognized by Pasha (or
DGCR8 in vertebrates), which is essential for the RNase
III enzyme Drosha processing of the hairpin structure.
This cleavage generates a 55–70 pre-miRNA hairpin that
is exported to the cytoplasm assisted by exportin-5.
Once in the cytoplasm, the terminal loop is split from
the structure by the RNase III enzyme Dicer. Then, the
duplexes are unwound to load the mature strand into an
Argonaute containing RNA-induced silencing complex
(RISC) [19,20]. The first 2-8 nucleotides (seed) of the miR-
NAs are essential in the recognition of the target, the
complementarity can be complete or partial, and leads to
mRNA translational repression or destabilization.
In this paper, the expression of microRNAs in sub-
clinically PCV2 infected pigs was analysed using high
throughput sequencing.
Material and methods
Animal infection
Six 6-week-old Landrace x Large White pigs were used.
Four of them were intranasally inoculated with a totaldose of 7 × 104.8TCID50 of PCV2 genotype b isolate Sp-
10-7-54-13 [21], while 2 control pigs received PBS by
the same route. At 21 days post-inoculation (dpi), ani-
mals were euthanized. Samples from eight tissues:
spleen, inguinal lymph node, kidney, tonsil, thymus, me-
diastinal lymph node (MLN), lung and mesenterical
lymph node, were collected in duplicate and immediately
frozen in liquid nitrogen and stored at −80 °C. A third
sample was collected in formalin for histopathological
studies. Tissue sections were stained with haematoxylin
and eosin, and in situ hybridization (ISH) was carried
out in order to detect viral genome.
All animal experiments were performed in the CReSA
facilities, and all procedures were carried out according
to the guidelines of the institutional animal ethics com-
mittee of UAB, preserving the Spanish and European
animal experimentation ethics law.Homogenate and DNA- RNA extraction
Tissue samples of approximately 100 mg were homoge-
nated with a pestle in 1 mL of Trizol (Invitrogen, Carlsbad,
USA) to lyse the tissues and deactivate virus. Total RNA
and DNA were isolated following the manufacturer’s
protocol and resuspended in 25 and 200 μL of RNAse-,
DNAse- and proteinase free water (Sigma) for RNA and
DNA, respectively.Quantitative real time PCR to detect PCV2
A quantitative real-time PCR (qPCR) was performed in
the 8 tissues from all animals to quantify PCV2 load.
Probe and primers used for the procedure were those
designed and used in [22]. The mix for the qPCR con-
tained 900 nM primers PCV2F and PCV2R, 150 μM
probe, 0.4 μL IC kit, 12.5 μL Taqman Universal Master
Mix and 2.5 μL template. Nanopure autoclaved water
was added to final volume of 25 μL. The conditions for
the amplification were 10 min at 95 °C, 2 min at 50 °C
and 40 cycles of 15 s at 95 °C and 1 min at 60 °C. Tripli-
cates of each sample were used for the qPCR.RNA integrity and quantification
Total RNA was quantified using ND 1000 Nanodrop®
Spectrophotometer (Thermo Scientific, Wilmington,
USA). RNA integrity and quality was analysed using
the 2100 Expert Bioanalizer (Agilent Technologies,
Santa Clara, USA). Total and low size RNA measure-
ments were carried out. Total RNA was calculated
using the Eukaryote total RNA Nano Series II software
and specific chips (Agilent Technologies, Santa Clara,
USA), while low size RNA was measured using the
Small RNA Nano software and specific chips (Agilent
Technologies, Santa Clara, USA).
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All procedures were carried out using the miRCat™
microRNA Cloning Kit (IDT, Iowa, USA) protocol as
basis, with the modifications described in [23]. For the
enrichment of the small RNA fraction, slices were cut
from a 12% denaturing (7 M Urea) polyacrylamide gel,
using a miSPIKE™ (IDT, Iowa, USA), as internal size
marker. Small RNA fractions were purified using Performa
DTR gel filtration cartridges (EdgeBio, Gaithersburg,
USA). A double ligation was carried out using 3′ and 5′
linkers from miRCatTM kit (IDT, Coralville, USA) in two
steps. The 3′ preadenylated linker was coupled to the
small RNA fraction in a reaction in which the mix
contained 1X Reaction Buffer for T4 Ligase (Thermo
Fisher Scientific, Walthman, MA) without ATP, 0.1 mg
BSA (Fermentas), 1U T4 RNA ligase (Fermentas) and 2.5
μM 3′ linker. 6.5 μL small RNA fraction was added and
incubated at 37 °C for 2 h. The 5′ linker was coupled in a
mix with 1X ligation buffer (Ambion), 1U T4 RNA ligase
(Ambion) and 50 μM 5′ linker in presence of ATP. 7.5 μL
3′linked RNA was added to a final volume of 10 μL. The
mixture was incubated for 2 h at 37 °C.RT- PCR
RT was carried out with Super Script III Reverse Tran-
scriptase (Life Technologies). Initial pre incubation at 65 °C
for 5 min with 0.5 mM of each dNTP, 0.5 μM Primer mir5
and 11 μL RNA were carried out. In a second step a mix
was prepared with 1X First-Strand Buffer, 5 mM DTT, 0.2
U RNaseOUT and 10 U SuperScript III RT in a final vol-
ume of 20 μL, the mix was incubated at 55 °C for 90 min,
and 70 °C for 15 min.
PCR amplifications were performed using Expand
High Fidelity Plus PCR System (Roche). Briefly, 0.05 U
Expand High Fidelity Plus Enzyme Blend, 1X Expand
High Fidelity Plus Reaction Buffer with 1.5 mM MgCl2,
0.2 μM Primers A5 and B3, 0.2 μM of each dNTP, 4 μL
cDNA and RNAse Free Water to a final volume of 50
μL. Primers A3 and B5 were designed as fused primers
with sequence primers mir5 or mir3 (IDT, Iowa, USA)
plus sequence primers A or B (454 GS-FLX Roche), re-
spectively, labelled with a five nucleotide sequence tag
for differentiating libraries. PCR conditions were 94 °C
for 3 min, 20-25 cycles at 94 °C for 30 s, 57 °C for 45 s
and 72 °C for 1 min followed by 71 °C for 7 min. The
number of cycles was optimized for each library to avoid
saturation. The resulting PCR was purified with the
QIAquick PCR purification kit (Qiagen).
Cloning in pGEM-T Easy Vector System II Kit (Promega)
and posterior Sanger sequencing with the ABI-PRISM
3700 (Applied Biosystems) were carried out to check
the libraries construction prior to the high throughput
sequencing.High throughput sequencing
Amplicons were quantified using Qubit™ fluorometer,
Quant-IT™ (Invitrogen™, Carlsbad, USA), prepared to a
1011 DNA molecules/μL and equimolecular pooled. Li-
braries were sequenced following the manufacturer’s
protocol with the 454 GS-FLX System (Roche) at the
DNA sequencing facilities at CRAG (Centre de Recerca
Agrogenòmica, Universitat Autònoma de Barcelona,
Spain). Sequencing data have been submitted to the
European Nucleotide Archive (ENA) [24] with the ac-
cession number PRJEB7603.
Sequence processing scheme
Primer sequences were trimmed and only those insert
sequences between 15 and 29 nucleotides and with total
number of sequences ≥3 were kept for further analysis.
For porcine miRNA profiling, sequences were com-
pared to all available miRNA sequences (miRBase v20)
using local Blast. Parameters were set to 100% identity
and up to 4 mismatches allowed at the end of the se-
quences to solve the miRNA variability on 3′ and 5′
ends [25].
Differences in host miRNA expression were assessed.
The total number of sequences obtained for each porcine
miRNA was normalised by library size (in counts per
thousand) and, then, averaged by group. Fold changes
(FC) between groups were calculated using normalised
data. Only miRNAs up or down-regulated for all individ-
uals per group were taking into account.
miRNAs target prediction and biological functions
For the in silico study of the potential targets, the
DIANA-microT v5.0 web server with an adjusted thresh-
old of 0.7 was used [26,27]. There were no porcine genes
in the databases, so the study was done using the human
genome assuming sequence conservation [28]. In order
to identify potential targets in the viral genome, miRanda
program was used with the following parameters: -sc 140 –
en 20. Potential targets were then studied employing Web-
based Gene Set Analysis Toolkit (WebGestal) [29,30]. The
analysis was done using the Kyoto Encyclopedia of Genes
and Genomes Database (KEGG) to check the biological
pathways in which miRNAs are involved. The selected pa-
rameters for the study were the multiple test adjustment by
Benjamini and Hochberg [31] and the significance level set
at 0.05.
Results
Experimental infection
Until 21 dpi no animals developed clinical signs. PCV2
infection was confirmed in inoculated animals by qPCR
in 6 out of 8 tissues: Spleen, inguinal lymph node, tonsil,
MLN, lung and mesenteric lymph node, confirming
the subclinical nature of the infection (Table 1). No
Table 1 Genome copies/mg detected by qPCR in tissues
of infected (number 3 to 6) and non-infected (number 1
and 2) pigs with PCV2
Animal number
Tissue 1 2 3 4 5 6
Spleen - - 3.2 × 102 2.9 × 102 7.2 × 101 4 × 102
Inguinal ln - - 1.2 × 104 3.3 × 102 1.7 × 103 8.9 × 102
Kidney - - - - - -
Tonsil - - 5.2 × 101 1.8 × 103 2.1 × 103 8 × 102
Thymus - - - - - -
Mediastinal ln - - 8.2 × 103 1.9 × 104 3.8 × 104 4.6 × 104
Lung - - 6 × 101 2.1 × 102 1.1 × 102 9.2 × 101
Mesenteric ln - - 2.5 × 102 7.6 × 102 7.2 × 101 1.1 × 103
Table 3 Differentially expressed miRNAs in the MLN
miRNA Inf/non inf Reads
ssc-miR-126-5p 6.28 18 794
ssc-miR-126-3p 7.51 17 050
ssc-miR-193a-5p −54.29 3139
ssc-let-7d-3p 9.3 770
hsa-miR-574-5p −19.9 310
ssc-miR-34a −5.34 165
ssc-miR-129a 8.28 115
hsa-let-7b-3p 6.5 83
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in kidney and thymus of tested animals. PCV2 detec-
tion by in situ hybridization was negative for all sam-
ples tested. No histological lesions were observed at
necropsy. MLN and tonsil were selected for small
RNA library construction because of their viral load
and because tonsil is the primary replication site.
miRNA sequence annotation
A total of 12 small RNA libraries were constructed and
sequenced. From the total reads obtained (1 106 437),
after trimming the adaptors sequences, and selecting in-
serts ranging from 15 to 29 nt, a total of 796 710 reads
were obtained (Table 2). Reads were aligned to the miR-
Base database (v20), not allowing any changes inside but
allowing a maximum of four changes in the sequence
extremes. Finally, 562 483 reads (4700 unique sequences)
were aligned to miRBase. A total of 508 miRNAs were
described.
Differential expression analysis
miRNAs were considered differentially expressed (DE)
when fold change (FC) difference between infected and
non-infected animals was higher than 5 and when the
up- or down-regulation was conserved for all animals
per group. From the 119 miRNAs highly expressed (>80
reads) in MLN, 8 miRNAs were DE, five up-regulated
(mir-126-3p, mir-126-5p, let-7d-3p, mir-129a, mir-let-
7b-3p) and three down-regulated (mir-193a-5p, mir-
574-5p and mir-34a) (Table 3). In tonsil, no miRNATable 2 High throughput sequencing reads
Total reads 1 106 437
Trimed, not empty reads, ranging from 15 to 29 nt 796 710
Aligned to miRBase 562 483
Unique sequences 4700
Number of miRNAs 508was DE from the 115 miRNAs with more than 80
reads.
Target prediction and functional analysis
Diana micro-T was employed to identify putative targets
for eight selected DE miRNAs. A list of 5502 target
genes was identified (see Additional file 1). A gene
ontology (GO) enrichment analysis was used to identify
the functions of the target genes (Table 4). No significant
related pathways were found for mir-let-7d-3p and ssc-
miR-126-3p. Some pathways related to viral infection
process and immune response were found to be signifi-
cant, such as the T cell receptor signalling pathway, Fc
gamma R-mediated phagocytosis and the Fc epsilon RI
signalling pathway. The prediction of putative targets in
viral genome indicated that two of the DE miRNAs tar-
geted the PCV2 genome: mir-let-7d-3p and mir-129a,
both targeting the Cap gene.
Discussion
miRNAs can be an important factor playing a role in
virus/host interaction and in the immune response in-
volved in the pathogenesis of PCV2 infection, in both
subclinical and clinical scenarios. This work is the first
study on miRNAs gene expression in pigs infected with
PCV2 using a deep sequencing approach. In the experi-
mental infection carried out, the lack of clinical signs,
histological lesions and viral detection by ISH and the
low viral load detected by qPCR is in agreement with
previous studies where a subclinical infection has been
developed [32].
Taking into account the comparison of the most
expressed miRNAs in both tissues (CN > 80), 74.8% of
the miRNAs were common. This is in concordance with
the lymphoid origin of both tissues. When comparing
the tissues analysed, the expression profile was affected
differentially by the PCV2 infection. The miRNA expres-
sion was affected notably in MLN, whereas in tonsil, the
miRNA expression pattern was less affected. A possible
factor affecting this expression is the difference in viral
load. However, differences in cytokine expression have
Table 4 Genome pathways predicted for selected miRNAs
from Kyoto Encyclopedia of Genes and Genomes, related
to the immune system and PCV2 pathogenesis
miRNA Genome pathway
ssc-miR-126-3p -
ssc-miR-126-5p T cell receptor signalling pathway
Natural killer cell mediated cytotoxicity
B cell receptor signalling pathway
Fc epsilon RI signalling pathway
Chemokine signalling pathway
mTor signalling pathway*
MAPK signalling pathway*
ssc-miR-193a-5p Cytosolic DNA-sensing pathway
ssc-let-7d-3p -
ssc-miR-34a Fc gamma R-mediated phagocytosis
Hematopoietic cell lineage
B cell receptor signalling pathway
Fc epsilon RI signalling pathway
T cell receptor signalling pathway
Natural killer cell mediated cytotoxicity
Leukocyte transendothelial migration
MAPK signalling pathway*
hsa-miR-574-5p T cell receptor signalling pathway
MAPK signalling pathway*
hsa-let-7b-3p T cell receptor signalling pathway
Chemokine signalling pathway
Fc gamma R-mediated phagocytosis
Leukocyte transendothelial migration
NOD-like receptor signalling pathway
Hematopoietic cell lineage
B cell receptor signalling pathway
Toll-like receptor signalling pathway
MAPK signalling pathway*
ssc-miR-129a Fc epsilon RI signalling pathway
B cell receptor signalling pathway
Chemokine signalling pathway
MAPK signalling pathway*
*Signal transduction.
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[9] although the basis of this differential expression is
not clear. Thus, the conserved miRNA expression in
tonsil could be associated to this different cytokine ex-
pression. On the other hand, tonsil has been suggested
as a primary replication site for PCV2 [2]. Because all
animals were euthanized at day 21, the expression of
miRNA could be altered by the differences in the period
of time when the tonsil and MLN were infected [33].Differential expression of miRNAs in MLN is high due
to the PCV2 infection; from the most represented miR-
NAs in both tissues (CN > 80): mir-126-3p, mir-126-5p,
mir-let-7d-3p, miR-129-2-3p and mir-let-7b-3p were
up-regulated in MLN of PCV2 infected animals, while
miR-193a-5p, miR-574-5p and miR-34a-5p were down-
regulated.
miRNAs DE could regulate genes that would be in-
volved in the immune response, such as T cell receptor
signalling pathways, natural killer cell mediated cytotox-
icity, the B cell receptor signalling pathway, the chemokine
signalling pathway, Fc gamma R- mediated phagocytosis,
leukocyte transendothelial migration, the cytosolic DNA
sensing pathway, the NOD-like receptor signalling path-
way, hematopoietic cell lineage and also related to Fc epsi-
lon R-I signalling pathways.
miR-126-5p is the most represented miRNA DE in
MLN and has been involved in the intracellular expression
of Toll-like receptors (TLRs) 7 and 9 by plasmacytoid den-
dritic cells, producing (anti-viral) type I interferons [34],
thus, mir-126-5p can modulate the physiopathology of the
immune response against PCV2. The extracellular signal-
regulated kinase (ERK) signalling pathway, one of the
three mitogen-activated protein kinase (MAPK), has been
shown to be involved in the induction of autophagy by
PCV2 [35] and the inhibition of ERK signalling pathways
increases PCV2 replication [36]. In our functional analysis,
miR-126-5p was associated with the MAPK signalling
pathway, therefore, this miRNA could be involved in both
processes.
TFPI (tissue factor pathway inhibitor) is one of the genes
targeted by miR-126-5p. Comparison with a previous
study [32] in which gene expression in response to PCV2
infection was analyzed by microarray hybridization,
showed a TFPI gene down-regulation in MLN. This de-
creased expression could inhibit migration and cell prolif-
eration and thus, could be involved in the inflammatory
process developed in pigs with PCV2-SD [32]. On the
other hand, in a coxsackievirus infection, miR-126 targets
SPRED1, LRP6, and WRCH1 genes, mediating cross-talk
between the ERK1/2 and Wnt/β-catenin pathways, enhan-
cing viral replication and contributing to the viral cyto-
pathogenicity [37].
Target prediction analysis indicated that miR-126-3p
was potentially able to regulate only 20 genes but no
related pathways were found. Interestingly, one of the
targeted genes is the previously mentioned SPRED1,
shared with miR-126-5p.
miR-let-7b-3p was up-regulated in MLN and has been
shown to be able to potentially regulate a great number
of genes, thereby several immunological pathways have
been found for this miRNA. Besides this, this miRNA
has also been associated with the MAPK signaling path-
way. Target prediction analysis showed that miR-let-7b-3p
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involved in the modulation of Toll-like receptor 3 (TLR 3)
signaling [38].
mir-let-7d-3p was up-regulated in MLN, although 13
genes were found as potentially regulated by this miRNA,
no related immunological pathways were found. miR-
193a-5p was down-regulated in medistinal lymph node,
and could potentially regulate genes related to the cyto-
solic DNA- sensing pathway.
miR-34a-5p is down-regulated in MLN and this
regulatory role was predicted to be involved in several
immunological pathways and the MAPK signalling path-
way. In this case, target prediction analysis revealed that
miR-34a-5p targets KLRK1, killer cell lectin-like receptor
subfamily K, member 1, which binds to a diverse family
of ligands that include MHC class I chain-related A and
B proteins and UL-16 binding proteins, where ligand-
receptor interactions can result in the activation of NK
and T cells [39]. It also regulates ARHGP6, a member of
the Rho family that participates in endocytosis processes.
PCV2 internalization is produced mainly by endocytosis,
mainly through Rho- GTPase mediated dynamin- inde-
pendent pathway [32].
miR-574-5p was down-regulated in MLN and was
predicted to be involved in the regulation of the T cell
receptor signalling and MAPK signalling pathways. miR-
129-2-3p was down-regulated in MLN, predicted path-
ways in which this miRNA was involved were the Fc
epsilon RI signalling, the MAPK signalling, the B cell re-
ceptor signalling, and chemokine signalling pathways.
This miRNA has previously been described as targeting
transcription factor SOX4 which has a critical function
in normal B-cell ontogenesis [40].
Some of the predictions described in this work could
be involved in the manifestation of the pathogenesis of
the subclinically infected animals, but at this point, we
want to indicate that further functional assays are
needed to confirm the computational predictions of
miRNAs target genes and the regulation of the pathways
described.
The effect of host miRNAs on viral gene expression
was analyzed using miRanda. Thus, mir-126-3p and mir-
126-5p, the most represented DE miRNAs, showed no
targets in the viral genome, while mir-let-7d-3p and mir-
129a presented targets in the Cap gene of PCV2. Both
miRNAs are up-regulated in MLN and can affect viral
replication as has been seen for others viruses where
several miRNAs can down-regulate the expression of
viral proteins [41,42]. Nevertheless, the role of host miR-
NAs in the regulation of the viral replication is contro-
versial as has been revealed in an extensive study [43].
The authors showed that many human viruses are re-
fractory to inhibition by host miRNAs due to miRNA
driven viral evolution. Thus, experimental assays areneeded to clarify if PCV2 is regulated or not by porcine
miRNAs.
The identification of the DE miRNAs and the predic-
tion analysis regarding the functions of these miRNAs in
an in vivo PCV2 infection in its natural host has been
described in this study. The two tissues analysed pre-
sented a different behaviour in their miRNA expression
pattern in response to the infection.
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